Logo Université Laval Logo Université Laval
International Chair on Cardiometabolic Risk
My Healthy Waist

Documentation centre

1897-1908 of 2541 results
Page 159 of 212
Key Publications March 31, 2017

Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.

J Hypertens. 2017;35:55-62

Oh JY, Allison MA, Barrett-Connor E
Cardiovascular Disease Diabetes Hypertension
Key Publications March 30, 2017

Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes.

N Engl J Med. 2016;375:2144-2153

Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, Voros S, Giugliano RP, Davey Smith G, Fazio S, Sabatine MS
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications March 30, 2017

Recommended dietary pattern to achieve adherence to the American Heart Association/American College of Cardiology (AHA/ACC) guidelines: A scientific statement from the American Heart Association.

Circulation. 2016;134:e505-e529

Van Horn L, Carson JA, Appel LJ, Burke LE, Economos C, Karmally W, Lancaster K et al.
Cardiovascular Disease Nutrition Prevention
Expert Opinions March 29, 2017

What are the most exciting developments in lipidology?

Philip J. Barter, MD, MBBS, FRACP, PhD, Conjoint Professor, University of New South Wales, Sydney, Australia
Cardiovascular Disease Lipids/Lipoproteins Prevention
Key Publications March 29, 2017

The risk continuum of atherosclerosis and its implications for defining CHD by coronary angiography.

J Am Coll Cardiol. 2016;68:2467-2478

Arbab-Zadeh A, Fuster V
Cardiovascular Disease Clinical Cardiology Prevention
Key Publications March 29, 2017

A test in context: Hemoglobin A1c and cardiovascular disease.

J Am Coll Cardiol. 2016;68:2479-2486

Gore MO, McGuire DK
Cardiovascular Disease Diabetes Prevention
Key Publications March 29, 2017

Treatment with dalcetrapib modifies the relationship between high-density lipoprotein cholesterol and C-reactive protein.

J Am Coll Cardiol. 2016;68:2488-2490

Pitts R, Gunzburger E, Ballantyne CM, Barter PJ, Kallend D, Leiter LA, Leitersdorf E, McMurray JJ, Nicholls SJ, Niesor EJ, Olsson AG, Shah PK, Tardif JC, Kittelson J, Schwartz GG
Cardiovascular Disease Inflammation Lipids/Lipoproteins
Key Publications March 28, 2017

High-sensitivity C-reactive protein and risk of stroke in atrial fibrillation (from the Reasons for Geographic and Racial Differences in Stroke study).

Am J Cardiol. 2016;118:1826-1830

Dawood FZ, Judd S, Howard VJ, Limdi NA, Meschia JF, Cushman M, Howard G, Herrington DM, Soliman EZ
Cardiovascular Disease Ethnicity Inflammation
Key Publications March 27, 2017

Impact of Lipoprotein(a) on long-term outcomes in patients with diabetes mellitus who underwent percutaneous coronary intervention.

Am J Cardiol. 2016;118:1781-1785

Konishi H, Miyauchi K, Shitara J, Endo H, Wada H, Doi S, Naito R, Tsuboi S, Ogita M, Dohi T, Kasai T, Okazaki S, Isoda K, Suwa S, Daida H
Cardiovascular Disease Diabetes Lipids/Lipoproteins
Key Publications March 27, 2017

Targeted multiple biomarker approach in predicting cardiovascular events in patients with diabetes.

Heart. 2016;102:1963-1968

Resl M, Clodi M, Vila G, Luger A, Neuhold S, Wurm R, Adlbrecht C, Strunk G, Fritzer-Szekeres M, Prager R, Pacher R, Hülsmann M
Cardiovascular Disease Diabetes Metabolism
Key Publications March 24, 2017

Trends in the epidemiology of cardiovascular disease in the UK.

Heart. 2016;102:1945-1952

Bhatnagar P, Wickramasinghe K, Wilkins E, Townsend N
Cardiovascular Disease Epidemiology Sex Differences
Key Publications March 24, 2017

Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care.

Heart. 2016;102:1957-1962

Emanuel G, Charlton J, Ashworth M, Gulliford MC, Dregan A
Cardiometabolic Risk Cardiovascular Disease Inflammation
of 212